SJS/TEN 2019: From Science to Translation

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are potentially life-threatening, immune-mediated adverse reactions characterized by widespread erythema, epidermal necrosis, and detachment of skin and mucosa. Efforts to grow and develop functional international collaborations and a multidisciplinary interactive network focusing on SJS/TEN as an uncommon but high burden disease will be necessary to improve efforts in prevention, early diagnosis and improved acute and long-term management. SJS/TEN 2019: From Science to Translation was a 1.5-day scientific program held April 26-27, 2019, in Vancouver, Canada. The meeting successfully engaged clinicians, researchers, and patients and conducted many productive discussions on research and patient care needs.

Citing Articles

Spatial proteomics identifies JAKi as treatment for a lethal skin disease.

Nordmann T, Anderton H, Hasegawa A, Schweizer L, Zhang P, Stadler P Nature. 2024; 635(8040):1001-1009.

PMID: 39415009 PMC: 11602713. DOI: 10.1038/s41586-024-08061-0.

Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review.

Zhang X, Huang D, Lou D, Si X, Mao J BMC Endocr Disord. 2024; 24(1):172.

PMID: 39218880 PMC: 11367887. DOI: 10.1186/s12902-024-01683-5.

The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) - Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions.

James F, Goh M, Vogrin S, Ng I, Douglas A, Holmes N World Allergy Organ J. 2024; 17(8):100936.

PMID: 39211425 PMC: 11357849. DOI: 10.1016/j.waojou.2024.100936.

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Analysis of the Russian Database of Spontaneous Reports.

Zyryanov S, Asetskaya I, Butranova O, Terekhina E, Polivanov V, Yudin A Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931343 PMC: 11207115. DOI: 10.3390/ph17060675.

Updates in SJS/TEN: collaboration, innovation, and community.

Marks M, Botta R, Abe R, Beachkofsky T, Boothman I, Carleton B Front Med (Lausanne). 2023; 10:1213889.

PMID: 37901413 PMC: 10600400. DOI: 10.3389/fmed.2023.1213889.

References

White K, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B . SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. J Allergy Clin Immunol Pract. 2018; 6(1):38-69. PMC: 5857362. DOI: 10.1016/j.jaip.2017.11.023. View

Kreft B, Lieser U, Haase R, Marsch W, Wohlrab J . Extensive hypertrophic scarring after toxic epidermal necrolysis in a child. Pediatr Dermatol. 2012; 31(4):527-8. DOI: 10.1111/j.1525-1470.2012.01863.x. View

Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck J, Halevy S . Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013; 133(5):1197-204. DOI: 10.1038/jid.2012.510. View

Paquet P, Jacob E, Quatresooz P, Jacquemin D, Pierard G . Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis. Burns. 2006; 33(1):100-4. DOI: 10.1016/j.burns.2006.04.031. View

Chen C, Hsiao Y, Wu T, Hsih M, Tassaneeyakul W, Jorns T . Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. Neurology. 2016; 88(1):78-86. DOI: 10.1212/WNL.0000000000003453. View

Sharma N, Thenarasun S, Kaur M, Pushker N, Khanna N, Agarwal T . Adjuvant Role of Amniotic Membrane Transplantation in Acute Ocular Stevens-Johnson Syndrome: A Randomized Control Trial. Ophthalmology. 2015; 123(3):484-91. DOI: 10.1016/j.ophtha.2015.10.027. View

Hefez L, Zaghbib K, Sbidian E, Valeyrie-Allanore L, Allain M, Duong T . Post-traumatic stress disorder in Stevens-Johnson syndrome and toxic epidermal necrolysis: prevalence and risk factors. A prospective study of 31 patients. Br J Dermatol. 2018; 180(5):1206-1213. DOI: 10.1111/bjd.17267. View

Paulmann M, Mockenhaupt M . Fever in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Cases: Laboratory Work-up and Antibiotic Therapy. Pediatr Infect Dis J. 2017; 36(5):513-515. DOI: 10.1097/INF.0000000000001571. View

McCormack M, Gui H, Ingason A, Speed D, Wright G, Zhang E . Genetic variation in predicts phenytoin-induced maculopapular exanthema in European-descent patients. Neurology. 2017; 90(4):e332-e341. PMC: 5798660. DOI: 10.1212/WNL.0000000000004853. View

10.

Kohanim S, Palioura S, Saeed H, Akpek E, Amescua G, Basu S . Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. Ocul Surf. 2016; 14(2):168-88. DOI: 10.1016/j.jtos.2016.02.001. View

11.

Ko T, Tsai C, Chen S, Chen K, Yu K, Chu C . Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ. 2015; 351:h4848. PMC: 4579807. DOI: 10.1136/bmj.h4848. View

12.

Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K . ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010; 88(1):60-8. DOI: 10.1038/clpt.2009.252. View

13.

Miletta N, Donelan M, Hivnor C . Management of trauma and burn scars: the dermatologist's role in expanding patient access to care. Cutis. 2017; 100(1):18-20. View

14.

Zhang F, Liu H, Irwanto A, Fu X, Li Y, Yu G . HLA-B*13:01 and the dapsone hypersensitivity syndrome. N Engl J Med. 2013; 369(17):1620-8. DOI: 10.1056/NEJMoa1213096. View

15.

Gonzalez-Herrada C, Rodriguez-Martin S, Cachafeiro L, Lerma V, Gonzalez O, Lorente J . Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches. J Invest Dermatol. 2017; 137(10):2092-2100. DOI: 10.1016/j.jid.2017.05.022. View

16.

Shanbhag S, Rashad R, Chodosh J, Saeed H . Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Am J Ophthalmol. 2019; 208:331-341. PMC: 7935472. DOI: 10.1016/j.ajo.2019.07.006. View

17.

Mallal S, Phillips E, Carosi G, Molina J, Workman C, Tomazic J . HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008; 358(6):568-79. DOI: 10.1056/NEJMoa0706135. View

18.

Niemeijer I, van Praag M, Van Gemund N . Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology. Arch Gynecol Obstet. 2009; 280(5):851-4. DOI: 10.1007/s00404-009-1008-1. View

19.

Nicoletti P, Barrett S, McEvoy L, Daly A, Aithal G, Lucena M . Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions. Clin Pharmacol Ther. 2019; 106(5):1028-1036. PMC: 7156285. DOI: 10.1002/cpt.1493. View

20.

Chung W, Hung S, Yang J, Su S, Huang S, Wei C . Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med. 2008; 14(12):1343-50. DOI: 10.1038/nm.1884. View